|
2024
|
Invention
|
Dual-function protein for lipid and blood glucose regulation.
The present disclosure relates to ... |
|
2023
|
Invention
|
Antibody binding tissue factor pathway inhibitor and use of antibody. Provided is an antibody spe... |
|
|
Invention
|
Anti-tfpi antibody having binding specificity and use thereof. Provided are an antibody specifica... |
|
|
Invention
|
Linker peptide for constructing fusion protein.
A linker peptide for constructing a fusion prote... |
|
|
Invention
|
Monoclonal antibody against tfpi and use thereof. Provided are an antibody or an antigen-binding ... |
|
2022
|
Invention
|
Uses of fgf21 fusion proteins. The present disclosure provides human fibroblast growth factor 21 ... |
|
|
Invention
|
Anti-b7-h3 monoclonal antibody and use thereof.
Provided in the present invention are an antibod... |
|
|
Invention
|
Anti-cd3 antibody and use thereof.
Provided in the present invention is an antibody against huma... |
|
|
Invention
|
Anti-b7-h3 monoclonal antibody and use thereof. Provided in the present invention are an antibody... |
|
|
Invention
|
Anti-cd3 antibody and use thereof. Provided in the present invention is an antibody against human... |
|
|
Invention
|
Antibody or antigen-binding fragment thereof for novel coronavirus nucleocapsid protein, and appl... |
|
2021
|
Invention
|
Anti-cd47 antibody and use thereof. Provided are an antibody against CD47 and a use thereof in th... |
|
|
Invention
|
Linker peptide for constructing fusion protein. A linker peptide for constructing a fusion protei... |
|
|
Invention
|
Antibody against sars-cov-2 coronavirus s protein and application thereof. Provided are an antibo... |
|
|
Invention
|
Method for efficiently separating and purifying recombinant human coagulate factor viii fc fusion... |
|
2020
|
Invention
|
Fgf21 fc fusion protein, glp-1 fc fusion protein, and combination therapeutic agent comprising sa... |
|
|
Invention
|
Dual-function protein for lipid and blood glucose regulation. The present disclosure relates to a... |
|
2019
|
Invention
|
Anti-tigit antibody and use thereof. The present invention relates to the field of disease treatm... |
|
|
Invention
|
Homodimer-type bispecific antibody targeting cd19 and cd3, and preparation method therefor and ap... |
|
|
Invention
|
Homodimeric bispecific antibody, preparation method therefor and use thereof.
Provided is a tetr... |
|
|
Invention
|
Homodimeric bispecific antibody, preparation method therefor and use thereof. Provided is a tetra... |
|
|
Invention
|
Bispecific antibody binding to cd20 and cd3 and uses thereof.
Disclosed is a bispecific antibody... |
|
|
Invention
|
Bispecific antibody binding to cd20 and cd3 and uses thereof. Disclosed is a bispecific antibody ... |
|
|
Invention
|
Homodimer-type bispecific antibody against her2 and cd3 and use thereof.
A tetravalent, homodime... |
|
|
Invention
|
Homodimer-type bispecific antibody against her2 and cd3 and use thereof. A tetravalent, homodimer... |
|
|
Invention
|
Fusion protein of mutated single-chain human coagulation factor viii, preparation method therefor... |
|
|
Invention
|
Antibody against tim-3 and application thereof. Provided by the present invention are an antibody... |
|
|
Invention
|
Antibody against tim-3 and application thereof. CA 03098096 2020-10-22 ABSTRACT Provided by the p... |
|
|
Invention
|
Anti-lag-3 antibody and use thereof. The present invention relates to the field of treatment of d... |
|
2017
|
Invention
|
Anti-pd-1 antibody and use thereof. This disclosure provides an antibody specifically binding to ... |
|
|
Invention
|
Human fibroblast growth factor 21 (hfgf21) fusion protein, preparation method therefor, and use t... |
|
|
Invention
|
Human coagulation factor ix (fix) fusion protein, preparation method therefor, and use thereof. A... |
|
|
Invention
|
Human coagulation factor ix (fix) fusion protein, preparation method therefor, and use thereof. <... |
|
2016
|
Invention
|
Highly glycosylated human blood-clotting factor viii fusion protein, and manufacturing method and... |
